Hope for Torbay and South Devon patients with a long-term lung condition

Published: 19 October 2026

Patients with bronchiectasis could see new treatments on the horizon thanks to an international clinical trial taking place in Torbay.

Bronchiectasis is a long-term respiratory illness where airways in the lungs are widened and produce excess mucus. Patients can have recurrent chest infections and flare ups and medicines have traditionally only eased symptoms or reduced the risk of complications. Medications to address bronchiectasis itself have only recently been developed, and none are in regular use yet in the UK.

Three patients have been recruited to the AIRTIVITY trial at Torbay Hospital looking at an exciting new targeted anti-inflammatory treatment to help improve symptoms and quality of life in people with bronchiectasis. This equalled recruitment numbers at much larger specialist centres.

The trial is still in its early stages and will be ongoing for another year, with an option for patients to extend their treatment should they wish.

Principal Investigator Dr Louise Anning at Torbay and South Devon NHS Foundation Trust said: “There is so much international excitement about this new medication that the trial finished recruiting a year ahead of schedule. I’m so proud to be part of the Torbay team who worked really hard to make sure our patients had the opportunity to be part of this important study.”

Sub-Investigator Dr Ben Diggins and Respiratory Nurse Specialist Bianca Hulance who are supporting the trial have been awarded research associateships by the regional research delivery network (RRDN) to increase their focus on research work at Torbay and South Devon NHS Foundation Trust.

The trial is expected to last two years in total and the findings will be used to inform future patient care.

Jeanette Glynn is one of the patients taking part in the trial. Jeanette said: “I’ve had breathing problems throughout my life, but I’ve been able to manage them with the right information and medication. However, over the last few years, I’ve had several serious infections and have gone backwards and forwards to the doctors and hospital for treatment which involved antibiotics, steroids and even intravenous medication.

“It was on a follow up respiratory appointment I was approached by Dr Diggins and Bianca from the respiratory team who asked me if I wanted to better understand why I kept getting ill. They said there was a clinical trial coming up which might help me to better manage my condition.

“After some initial tests, I started the AIRTIVITY trial in March 2026 and since then, I’ve only had one flare up which is amazing. It’s the longest period without any infections for the last two years.

“Having access to the trial has been a gamechanger and I hope this is going to be me for the rest of my days. I feel like there’s light at the end of the tunnel now which I couldn’t see before.”